London’s medical research institute hopes a new project with an old friend will take seed in already fertile ground in China.
On Friday (July 18) Dr. David Hill, the scientific director of Lawson Health Research Institute, signed an agreement with the head of development at Yabao Pharmaceutical Group to fast-track the development of a drug that in animal trials boosted the chances of surviving sepsis by as much as 50 percent.
Sepsis is a leading killer worldwide, with about 18 million cases resulting in six million deaths each year, and Hill believes it’s underreported, possibly by tens of millions.
Read more